by TractManager | Oct 31, 2017 | Emerging Technology Report
Soliris is an intravenous humanized monoclonal antibody for the treatment of acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis. Soliris was initially Food and Drug Administration (FDA) approved in 2007 for the treatment of patients with...
by TractManager | Oct 31, 2017 | Health Technology Assessment
Health Problem: Osteoarthritis (OA) is a painful condition in which the cartilage between the bones degenerates, no longer providing a smooth, gliding surface for motion or adequate cushioning. Because OA damages the cartilage and may ultimately damage the bone, it...
by TractManager | Oct 26, 2017 | Clinical Utility Evaluation
This report evaluates the clinical utility for use of cell-free DNA (cfDNA) screening for sex chromosome aneuploidies (SCAs) in women with singleton or multiple gestation pregnancies. There has been a large uptake of cfDNA fetal screening for common trisomies in women...
by TractManager | Oct 24, 2017 | Emerging Technology Report
Kevzara is an injectable fully human monoclonal antibody directed against the interleukin-6 (IL-6) receptor for the treatment of moderately to severely active rheumatoid arthritis (RA) in adults who have had an inadequate response or are intolerant to 1 or more...
by TractManager | Oct 24, 2017 | Health Technology Assessment
Health Problem: In women, breast cancer is the second most common type of cancer and second most common cause of cancer death. Conventional mammography provides 2-dimensional (2D) views of the breasts with notable tissue overlap, in some cases obscuring lesions that...
Recent Comments